{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:24Z","timestamp":1792068864053,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20381"],"award-info":[{"award-number":["U22A20381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018559","name":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","doi-asserted-by":"publisher","award":["RC240665"],"award-info":[{"award-number":["RC240665"]}],"id":[{"id":"10.13039\/501100018559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["SQ2024YFC3500039"],"award-info":[{"award-number":["SQ2024YFC3500039"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013099","name":"Scientific Research Fund of Liaoning Provincial Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118812","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:21:44Z","timestamp":1790608904000},"page":"118812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity"],"prefix":"10.1016","volume":"143","author":[{"given":"Jichong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118812_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the tumor microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.bmc.2026.118812_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118812_bb0015","doi-asserted-by":"crossref","first-page":"24972","DOI":"10.1021\/acsnano.3c07183","article-title":"Hypoxia-responsive Golgi-targeted prodrug assembled with anthracycline for improved antitumor and Antimetastasis efficacy","volume":"17","author":"Guo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bmc.2026.118812_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103975","article-title":"A novel multifunctional 2-nitroimidazole-based bioreductive linker and its application in hypoxia-activated prodrugs","volume":"101","author":"Huang","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118812_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129484","article-title":"Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole","volume":"95","author":"Tsuji","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118812_bb0030","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/jacs.0c10245","article-title":"Hypoxia-triggered self-assembly of ultrasmall Iron oxide nanoparticles to amplify the imaging signal of a tumor","volume":"143","author":"Zhou","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118812_bb0035","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1021\/acs.jmedchem.3c00302","article-title":"Recent advances in pro-PROTAC development to address on-target off-tumor toxicity","volume":"66","author":"Chen","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118812_bb0040","doi-asserted-by":"crossref","first-page":"22055","DOI":"10.1021\/acs.jmedchem.5c02094","article-title":"Application of hypoxia-activated prodrugs in tumor therapy: design strategies and perspectives","volume":"68","author":"Liu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118812_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.158356","article-title":"Multi-dimensional insights into Brucea javanica (L.) Merr. In cancer treatment: current status, challenges and future directions","volume":"158","author":"Li","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2026.118812_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jconrel.2024.01.060","article-title":"Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy","volume":"367","author":"Yan","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.bmc.2026.118812_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111321","article-title":"Rapid discovery and biomimetic syntheses of two unusual hemiterpene-quassinoid adducts from Brucea javanica","volume":"37","author":"Duan","year":"2026","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmc.2026.118812_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/cancers14030539","article-title":"Multifaceted interplay between hormones, growth factors and hypoxia in the tumor microenvironment","volume":"14","author":"Lappano","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmc.2026.118812_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/jpbs.jpbs_951_24","article-title":"Optimization of extraction process of Total flavonoids from loquat leaves and its protective effect on H9C2 cells in hypoxia injury","volume":"16","author":"Ke","year":"2024","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.bmc.2026.118812_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118812_bb0075","first-page":"0651","article-title":"Progressive deactivation of hydroxylases controls hypoxia-inducible factor-1alpha-coordinated cellular adaptation to graded hypoxia","volume":"8","author":"Wang","year":"2025","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.bmc.2026.118812_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107161","article-title":"Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment","volume":"144","author":"Yuan","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118812_bb0085","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/j.apsb.2025.07.020","article-title":"Photodynamic enhancement of PROTAC prodrug activation in hypoxic tumors","volume":"15","author":"Fu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118812_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/bcb-2024-0162","article-title":"Hydrocortisone improves post-resuscitation myocardial dysfunction by inhibiting the NF-kappaB pathway","volume":"103","author":"Fang","year":"2025","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.bmc.2026.118812_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124083","article-title":"Hypoxia-responsive paclitaxel prodrugs: linker evaluation and NIR-triggered self-amplifying photodynamic-chemotherapy nanoplatform","volume":"330","author":"Lv","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.bmc.2026.118812_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.127804","article-title":"A turn on fluorescent probe for nitroreductase activity and its application in real-time imaging of tumor hypoxia","volume":"290","author":"Gao","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.bmc.2026.118812_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125326","article-title":"Nitroreductase-responsive gated mesoporous silica nanocarriers for hypoxia-targeted drug delivery","volume":"672","author":"Barros","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmc.2026.118812_bb0110","article-title":"A nitroreductase-activatable metabolic reporter for covalent labeling of pathological hypoxic cells in tumorigenesis","volume":"63","author":"Wang","year":"2024","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.bmc.2026.118812_bb0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41557-022-00964-7","article-title":"Controlled masking and targeted release of redox-cycling ortho-quinones via a C-C bond-cleaving 1,6-elimination","volume":"14","author":"Dunsmore","year":"2022","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmc.2026.118812_bb0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nprot.2016.034","article-title":"Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs","volume":"11","author":"O\u2019Connor","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2026.118812_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112686","article-title":"Significance of specific oxidoreductases in the design of hypoxia-activated prodrugs and fluorescent turn off-on probes for hypoxia imaging","volume":"14","author":"Janczy-Cempa","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmc.2026.118812_bb0130","article-title":"Development of GLUT1-targeted\/esterase-responsive brusatol prodrug liposomes for liver cancer therapy","volume":"527","author":"Liu","year":"2026","journal-title":"Chem Eng J"},{"key":"10.1016\/j.bmc.2026.118812_bb0135","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1039\/D4RA00497C","article-title":"Integration of O(2)-economised tumour-targeted photosensitive magnetic nanomaterials in the diagnosis and therapy of gastric cancer","volume":"14","author":"Situ","year":"2024","journal-title":"RSC Adv"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:36:00Z","timestamp":1792067760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"alternative-id":["S0968089626002683"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118812","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118812"}}